The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity

Biochemical Pharmacology

Volumn 72, Issue 4, 2006, Pages 474-485

  Fritzsche, Juliane ^a   Alban, Susanne ^b   Ludwig, Ralf J ^c   Rubant, Simone ^c   Boehncke, Wolf Henning ^c   Schumacher, Gabriele ^a   Bendas, Gerd ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Cell adhesion; Heparin; Inflammation; P selectin; Polysaccharides

Indexed keywords

CURDLAN; CURDLAN SULFATE 1; CURDLAN SULFATE 2; CURDLAN SULFATE 3; CURDLAN SULFATE 4; CURDLAN SULFATE 5; GLUCAN; HEPARIN DERIVATIVE; PADGEM PROTEIN; PHYCARIN; PHYCARIN SULFATE 1; PHYCARIN SULFATE 2; PHYCARIN SULFATE 3; PHYCARIN SULFATE 4; PHYCARIN SULFATE 5; PHYCARIN SULFATE 6; POLYSACCHARIDE SULFATE; PROTEIN ANTIBODY; PULLULAN; PULLULAN SULFATE 1; PULLULAN SULFATE 2; PULLULAN SULFATE 3; PULLULAN SULFATE 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; DRUG STRUCTURE; ENDOTHELIUM; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROSCOPY; MICROVASCULATURE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SULFATION; THROMBOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BETA-GLUCANS; BLOOD PLATELETS; CELL ADHESION; ENDOTHELIUM, VASCULAR; GLUCANS; HEPARIN; HUMANS; LEUKOCYTE ROLLING; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; P-SELECTIN; PLATELET ACTIVATION; POLYSACCHARIDES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFATES; U937 CELLS;

EID: 33745965444     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.05.006     Document Type: Article

References (45)

1. Steeber D.A., and Tedder T.F. Adhesion molecules direct lymphocyte recirculation and leukocyte emigration during inflammation. Immunol Res 22 (2000) 299-317
2. Ley K. The role of selectins in inflammation and disease. Trends Mol Sci 9 (2003) 263-268
3. Vestweber D., and Blanks J.E. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 79 (1999) 181-213
4. McEver R.P. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J 14 (1997) 585-591
5. Vanderslice P., Biediger R.J., Woodside D.G., Berens K.L., Holland G.W., and Dixon R.A.F. Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD. Pulm Pharm Therap 17 (2004) 1-10
6. Ates A., Kinikli G., Turgay M., and Duman M. Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Scand J Immunol 59 (2004) 315-320
7. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170 (2003) 191-203
8. Borsig L. Selectins facilitate carcinoma metastasis and heparin can prevent them. News Physiol Sci 19 (2004) 16-21
9. X. Science 250 (1990) 1130-1132
10. Norman K.E., Anderson G.P., Kolb H.C., Ley K., and Ernst B. Sialyl Lewis X (sLex) and a sLex mimetic, CGP69669A, disrupt E-selectin-dependent leukocyte rolling in vivo. Blood 91 (1998) 475-483
11. Tojo S.J., Yokata S., Koike H., Schultz J., Hamazume Y., Misugi E., et al. Reduction of rat myocardial ischemia and reperfusion injury by sialyl Lewis x oligosaccharide and anti-rat P-selectin antibodies. Glycobiology 6 (1996) 463-469
12. Kolb H.C., and Ernst B. Development of tools for the design of selectin antagonists. Chem Eur J 3 (1997) 1571-1578
13. Jacob G.C., Kirmaier C., Abbas S.Z., Howard S.C., Steininger C.N., Welpy J.K., et al. Binding of the Sialyl Lewis X to E-selectin as measured by fluorescence polarization. Biochemistry 34 (1995) 1210-1217
14. Beauharnois M., Lindquist K.C., Marathe D., Vanderslice P., Xia J., Matta K.L., et al. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin. Biochemistry 44 (2005) 9507-9519
15. Bendas G. Inhibitors of membrane receptors involved with leukocyte extravasation. Mini Rev Med Chem 5 (2005) 575-584
16. Somers W.S., Tang J., and Shaw G.D. Insight into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to Slex and PSGL-1. Cell 103 (2000) 467-479
17. Skinner M.P., Fournier D.J., Andrews R.K., Gorman J.J., Chesterman C.N., and Berndt M.C. Characterization of human platelet GMP-140 as a heparin-binding protein. Biochem Biophys Res Commun 164 (1989) 1373-1379
18. Skinner M.P., Lucas C.M., Burns G.F., Chesterman C.N., and Berndt M.C. GMP-140 binding to neutrophils is inhibited by sulfated glycans. J Biol Chem 266 (1991) 5371-5374
19. Zacharski L.R., and Ornstein D.L. Heparin and cancer. Thromb Haemost 80 (1998) 10-23
20. Mousa S.A. Heparin and low molecular weight heparin in thrombosis, cancer and inflammatory diseases. Meth Mol Med 93 (2004) 35-48
21. Elsayed E., and Becker R.C. The impact of heparin compounds in cellular inflammatory responses: a construct for future investigations and pharmaceutical developments. J Thrombos Thrombolysis 15 (2003) 11-18
22. Ludwig R.J., Boehme B., Podda M., Henschler R., Jager E., Tandi C., et al. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res 64 (2004) 2743-2750
23. Nelson R.M., Cecconi O., Roberts W.G., Aruffo A., Linhardt R.J., and Bevilacqua M.P. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 82 (1993) 3253-3258
24. Koenig A., Norgard-Sumnicht K., Linhardt R., and Varki A. Differential interactions of heparin and heparan sulfate proteoglycans with the selectins. J Clin Invest 101 (1998) 877-889
25. Xie X., Rivier A.S., Zakrzewicz A., Bernimoulin M., Zeng X.L., Wessel H.P., et al. Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides. J Biol Chem 275 (2000) 34818-34825
26. Gao Y., Li N., Fei R., Chen Z., Theng S., and Zeng X. P-selectin-mediated acute inflammation can be blocked by chemically modified heparin, RO-heparin. Mol Cells 19 (2005) 350-355
27. Wang L., Brown J.R., Varki A., and Esko J.D. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 110 (2002) 127-136
28. Wei M., Tai G., Gao Y., Li N., Huang B., Zhou Y., et al. Modified heparin inhibit P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions. J Biol Chem 279 (2004) 29202-29210
29. Höpfner M., Alban S., Schumacher G., Rothe U., and Bendas G. Selectin-blocking semisynthetic sulfated polysaccharides as promising anti-inflammatory agents. Pharm Pharmacol 55 (2003) 697-706
30. Yvin JC, Alban S, Franz G. Anti-inflammatory and healing medicine based on laminarin sulfate. PCT Int Appl Patent No WO 2002036132 (May 10, 2002).
31. Alban S., and Franz G. Partial synthetic glucan sulfates as potential new antithrombotics: a review. Biomacromolecules 2 (2001) 354-361
32. Alban S., and Franz G. Gas-liquid chromatography-mass spectrometry analysis of anticoagulant active curdlan sulfates. Semin Thromb Hemost 20 (1994) 152-158
33. Schumacher G., Höpfner M., Vogel J., Bakowsky U., Ikami T., Rothe U., et al. Ein dynamisches Testsystem zur Untersuchung Selektin-inhibierender Substanzen als potentiell antiinflammatorische Verbindungen. PharmInd 64 (2002) 808-815
34. Ludwig R.J., Schultz J.E., Boehncke W.H., Podda M., Tandi C., Krombach F., et al. Activated, not resting, platelets increase leukocyte rolling in murine skin utilising a distinct set of adhesion molecules. J Invest Dermatol 122 (2004) 830-836
35. Pouyani T., and Seed B. PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell 83 (1995) 333-343
36. Barker J.N. Adhesion molecules in cutaneous inflammation. Ciba Found Symp 189 (1995) 91-101
37. Robert C., Fuhlbrigge R.C., Kieffer J.D., Ayehunie S., Hynes R.O., Cheng G., et al. Interaction of dendritic cells with skin endothelium: a new perspective on immunosurveillance. J Exp Med 189 (1999) 627-636
38. Ludwig R.J., Schultz J.E., Boehncke W.H., Podda M., Tandi C., Krombach F., et al. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 122 (2004) 830-836
39. Matzner Y., Marx G., Drexler R., and Eldor A. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost 52 (1984) 134-137
40. Jones H., Paul W., and Page C.P. The effect of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin. Br J Pharmacol 135 (2002) 469-479
41. Xie X., Thorlacius H., Raud J., Hedqvist P., and Lindbom L. Inhibitory effect of locally administered heparin on leukocyte rolling and chemoattractant-induced firm adhesion in rat mesenteric venules in vivo. Br J Pharmacol 122 (1997) 906-910
42. Diamond M.S., Alon R., Parkos C.A., Quinn M.T., and Springer T.A. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18). J Cell Biol 130 (1995) 1473-1482
43. Wang L., Fuster M., and Esko J.D. Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol 6 (2005) 902-910
44. Lortat-Jacob H., Grosdidier A., and Imberty A. Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci USA 99 (2002) 1229-1234
45. Lau E.K., Allen S., Hsu A.R., and Handel T.M. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins. Adv Pro Chem 68 (2004) 351-391